Covaxin demonstrates robust safety, immunogenicity in children aged 2–18 years: Bharat Biotech
News The vaccine maker has five crore doses of Covaxin ready Bharat Biotech International Limited (BBIL) announced on Friday that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has …